← CARDINAL HEALTH INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net earnings $1.4b $1.3b $259.0m $1.4b ($3.7b) $612.0m ($932.0m) $262.0m $853.0m $1.6b
Net Income (Loss) Attributable to Parent $1.4b — $256.0m $1.4b ($3.7b) $611.0m ($933.0m) $261.0m $852.0m $1.6b
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $1.4b $1.3b — — — — — — — —
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $1.4b $1.3b — — — — — — — —
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $0 $0 — — — — — — — —
Net Income (Loss) Attributable to Noncontrolling Interest $4.0m $6.0m $3.0m $2.0m $3.0m $1.0m $1.0m $1.0m $1.0m $8.0m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $1.4b $1.3b $259.0m $1.4b ($3.7b) $612.0m ($932.0m) $262.0m $853.0m $1.6b
Amortization of Intangible Assets $355.0m $395.0m $574.0m $531.0m $512.0m $428.0m $311.0m $281.0m $264.0m $303.0m
Depreciation $277.0m $314.0m $446.0m $455.0m $405.0m $377.0m $412.0m $441.0m $470.0m $488.0m
Depreciation, Depletion and Amortization $641.0m $717.0m $1.0b $1.0b $913.0m $783.0m $692.0m $692.0m $710.0m $790.0m
Deferred Income Tax Expense (Benefit) $87.0m $291.0m ($1.0b) ($83.0m) ($961.0m) $496.0m $7.0m ($31.0m) ($104.0m) $243.0m
Provision for/(benefit from) deferred income taxes $87.0m $291.0m ($1.0b) ($83.0m) ($961.0m) $496.0m $7.0m ($31.0m) ($104.0m) $243.0m
Gain (Loss) on Sale of Assets and Asset Impairment Charges ($21.0m) ($18.0m) ($1.4b) $488.0m ($7.0m) ($79.0m) ($2.0b) ($1.2b) ($634.0m) ($18.0m)
Goodwill, Impairment Loss — — $1.4b — — $0 $2.1b $1.2b $675.0m —
Impairments and (gain)/loss on disposal of assets, net $21.0m $18.0m $1.4b ($488.0m) $7.0m $79.0m $2.0b $1.2b $634.0m $18.0m
Impairments and loss on sale of other investments — — — $3.0m $0 $0 $24.0m $7.0m $2.0m $3.0m
Net tax proceeds/(withholding) from share-based compensation $6.0m $26.0m ($3.0m) ($14.0m) $8.0m $8.0m ($19.0m) $56.0m $46.0m ($13.0m)
Share-based Payment Arrangement, Expense $111.0m $96.0m $85.0m $82.0m $90.0m $89.0m $81.0m $96.0m $121.0m $121.0m
Share-based Payment Arrangement, Noncash Expense $111.0m $96.0m $85.0m $82.0m $90.0m $89.0m $81.0m $96.0m $121.0m $244.0m
Share-based compensation $111.0m $96.0m $85.0m $82.0m $90.0m $89.0m $81.0m $96.0m $121.0m $244.0m
Gain (Loss) on Extinguishment of Debt $0 $0 ($2.0m) $0 ($16.0m) ($14.0m) ($10.0m) $0 $0 —
Income (Loss) from Equity Method Investments — — — — $2.0m — — — — —
Income Tax Expense (Benefit) $845.0m $630.0m ($487.0m) $386.0m ($79.0m) ($289.0m) $163.0m $376.0m $348.0m $532.0m
Other Nonoperating Income (Expense) ($5.0m) $5.0m ($23.0m) ($15.0m) $1.0m $47.0m ($16.0m) $4.0m $9.0m $41.0m
Changes in operating assets and liabilities:
Additional Financial Items
Acquisition of subsidiaries, net of cash acquired ($3.6b) ($132.0m) ($6.1b) ($82.0m) $0 ($3.0m) ($22.0m) ($10.0m) ($1.2b) ($5.2b)
Cash payments for interest $174.0m $200.0m $320.0m $285.0m $226.0m $182.0m $153.0m $203.0m $214.0m $315.0m
Gain (Loss) Related to Litigation Settlement $69.0m ($48.0m) ($159.0m) ($36.0m) ($5.7b) ($1.1b) ($109.0m) $302.0m ($78.0m) $185.0m
Goodwill $7.2b $7.2b $8.3b $8.4b $8.4b $8.0b $5.9b $4.6b $4.7b $9.7b
Increase (Decrease) in Accounts Payable $2.8b $564.0m $2.6b $1.9b ($162.0m) $2.3b $3.4b $2.7b $1.8b $2.7b
Increase (Decrease) in Inventories $1.2b $673.0m $1.2b $551.0m $409.0m $1.6b $1.1b $340.0m ($1.1b) $1.8b
Increase in accounts payable $2.8b $564.0m $2.6b $1.9b ($162.0m) $2.3b $3.4b $2.7b $1.8b $2.7b
Increase in trade receivables ($866.0m) ($665.0m) ($871.0m) ($751.0m) $82.0m ($904.0m) ($1.5b) ($947.0m) ($996.0m) ($833.0m)
Inventory Write-down — — — — — $197.0m — — — —
Net cash payments for income taxes $635.0m $686.0m $425.0m $311.0m $368.0m $273.0m ($766.0m) $156.0m $191.0m $444.0m
Other accrued liabilities and operating items, net ($147.0m) ($520.0m) $378.0m $193.0m $6.5b $452.0m $293.0m ($967.0m) ($433.0m) ($606.0m)
Proceeds from long-term obligations, net of issuance costs $0 $5.2b $3.0m $0 $0 — $0 $0 $1.1b $3.7b
Proceeds from net investment hedge terminations — — — — $0 $0 $71.0m $29.0m $34.0m $2.0m
Proceeds from short-term investment in time deposit — — — — — — $0 $0 $350.0m $200.0m
Provision for bad debts $73.0m $63.0m $111.0m $88.0m $106.0m $65.0m $68.0m $99.0m $36.0m $53.0m
Purchase of short-term time deposits — — — — — — $0 $0 ($550.0m) $0
Purchase of treasury shares ($651.0m) ($600.0m) ($550.0m) ($600.0m) ($350.0m) ($200.0m) ($1.0b) ($2.0b) ($750.0m) ($765.0m)
Reduction of long-term obligations ($6.0m) ($310.0m) ($954.0m) ($1.1b) ($1.4b) ($570.0m) ($885.0m) ($579.0m) ($783.0m) ($445.0m)
Restructuring Costs $19.0m $44.0m $150.0m $92.0m $109.0m $75.0m $59.0m $43.0m $87.0m $40.0m
Net Cash Provided by (Used in) Operating Activities $3.0b $1.2b $2.8b $2.7b $2.0b $2.4b $3.1b $2.8b $3.8b $2.4b
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $465.0m $387.0m $384.0m $328.0m $375.0m $400.0m $387.0m $481.0m $511.0m $547.0m
Payments to Acquire Businesses, Net of Cash Acquired $3.6b $132.0m $6.1b $82.0m $0 $3.0m $22.0m $10.0m $1.2b $5.2b
Gain (Loss) on Sale of Investments — — — $3.0m $0 ($2.0m) $2.0m $0 $0 $3.0m
Increase (decrease) in other investing items, net — — — — — — — $8.0m $18.0m $2.0m
Net Cash Provided by (Used in) Investing Activities ($4.1b) ($405.0m) ($5.6b) $338.0m $493.0m ($378.0m) $567.0m ($454.0m) ($1.8b) ($5.6b)
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt $0 $5.2b $3.0m $0 $0 — $0 $0 $1.1b $2.9b
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $50.0m $77.0m $0 $0 — — — — — —
Repayments of Long-term Debt $6.0m $310.0m $954.0m $1.1b $1.4b $570.0m $885.0m $579.0m $783.0m $445.0m
Payments for Repurchase of Common Stock $651.0m $600.0m $550.0m $600.0m $350.0m $200.0m $1.0b $2.0b $750.0m $765.0m
Payments of Ordinary Dividends, Common Stock $512.0m $577.0m $581.0m $577.0m $569.0m $573.0m $559.0m $525.0m $499.0m $494.0m
Purchase of noncontrolling interests ($10.0m) ($12.0m) ($106.0m) $0 — $0 $0 $3.0m $0 $12.0m
Dividends on common shares ($512) ($577) ($581) ($577) ($569) ($573) ($559) ($525) ($499) ($494)
Net Cash Provided by (Used in) Financing Activities ($1.1b) $3.7b ($2.3b) ($2.3b) ($2.2b) ($1.3b) ($2.5b) ($3.1b) ($847.0m) $1.9b
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($12.0m) ($2.0m) $4.0m $1.0m ($13.0m) $11.0m ($25.0m) ($8.0m) ($9.0m) ($3.0m)
Effect of exchange rates changes on cash and equivalents ($12.0m) ($2.0m) $4.0m $1.0m ($13.0m) $11.0m ($25.0m) ($8.0m) ($9.0m) ($3.0m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($12.0m) ($2.0m) $4.0m $1.0m $240.0m $636.0m $1.3b ($674.0m) $1.1b ($1.3b)
Net increase/(decrease) in cash and equivalents ($2.3b) $4.5b ($5.1b) $768.0m $240.0m $636.0m $1.3b ($674.0m) $1.1b ($1.3b)
Cash and equivalents at beginning of period $4.6b $2.4b $6.9b $1.8b $2.5b $2.8b $4.7b $4.0b $5.1b $3.9b
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — — — — — $4.7b $4.0b $5.1b $3.9b
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $174.0m $200.0m $320.0m $285.0m $226.0m $182.0m $153.0m $203.0m $214.0m $315.0m
Income Taxes Paid, Net $635.0m $686.0m $425.0m $311.0m $368.0m $273.0m ($766.0m) $156.0m $191.0m $444.0m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.